Company profile
22nd Century Group, Inc.
NASDAQ:XXIIMedicinal Chemicals and Botanical Products
Clinical trials (3)
| NCT ID | Phase | Status | Start | Completion | Sponsor name | Title |
|---|---|---|---|---|---|---|
| NCT03559725 | phase1 | completed | 2018-05-01 | 2018-10-04 | 22nd Century Group, Inc. | Evaluation of Abuse Liability of Very Low Nicotine (VLN) Mentholated Cigarettes |
| NCT03559751 | phase1 | completed | 2018-04-13 | 2018-09-06 | 22nd Century Group, Inc. | Evaluation of the Abuse Liability of Very Low Nicotine (VLN) Cigarettes |
| NCT01400815 | phase2 | completed | 2011-07-01 | 2012-12-01 | 22nd Century Limited, LLC | Randomized Trial to Evaluate the Effectiveness of X-22 as a Smoking Cessation Aid |
FDA applications (0)
No records yet.